Dillione Janet

SEC Form 4 insider trading activity

Dillione Janet has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Sep 19, 2026.

On the most recent filing, Dillione Janet is listed as Director at CorMedix Inc. Inside the rolling window, Dillione Janet reported no open-market purchases and 4 open-market sales totaling $1.2M in CRMD. The largest disclosed transaction in the window is a sale of 46,657 CRMD shares on Dec 2, 2025, worth $467K.

Companies traded

Other insiders at CRMD

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$1.2M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
CRMDSale$69KJan 22SEC ↗
CRMDSale$408KDec 11SEC ↗
CRMDSale$467KDec 4SEC ↗
CRMDSale$262KNov 26SEC ↗
Showing 1–4 of 4
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Nov 14, 2025CRMDSale$343K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Dillione Janet made?

Dillione Janet has filed 7 SEC Form 4 filings (16 transaction rows) across 1 company since 2025.

Which companies does Dillione Janet trade?

Dillione Janet has filed SEC Form 4 disclosures for 1 company, including CRMD.

When was Dillione Janet's most recent SEC Form 4 filing?

Dillione Janet's most recent SEC Form 4 filing on Tracefour is dated Sep 19, 2026.

What is Dillione Janet's total buy and sell value in the current window?

Inside the rolling retention window, Dillione Janet bought $0 and sold $1.2M based on SEC Form 4 filings.

What was Dillione Janet's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 46,657 CRMD shares on 2025-12-02, worth $467K, per SEC Form 4 filings.